← USPTO TTAB Proceedings

Opposition: EVOX THERAPEUTICS

Opposition TTAB91299125-20260331 Kind: OPP Mar 31, 2026

Abstract

D MOT FOR EXT W/ CONSENT Plaintiff: Evoxx technologies GmbH Defendant: Evox Therapeutics Limited Mark at issue: EVOX THERAPEUTICS

Filing Date

2025-05-19